RRMS: Disease PROgression and Myeloid Profiling After Bone Marrow TRANSPLANTation and Second Line Therapies

Abroad (travel likely)Recruiting

Conditions

Multiple Sclerosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

IRCCS San Raffaele, Milan, Italy
Contact: Study coordinator (Massimo Filippi, MD) · filippi.massimo@hsr.it · 00390226433054
Contact: Study coordinator (Anna A. Bellini, MD) · bellini.anna@hsr.it · 00390226432154

Study leads

Massimo Filippi
Principal Investigator
IRCCS San Raffaele

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection Sites and Relative Bioavailability Via Autoinjector (AI) Versus Syringe Subcutaneously in Participants With Multiple Sclerosis (MS)

Multiple Sclerosis

Abroad (travel likely)RecruitingPHASE2

Bihać, Bosnia and Herzegovina · Sarajevo, Bosnia and Herzegovina

Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype

Multiple Sclerosis · Sleep · Pain

Abroad (travel likely)RecruitingPHASE2

Ann Arbor, United States

Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)

Multiple Sclerosis

Abroad (travel likely)Recruiting

Bethesda, United States

Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis

Multiple Sclerosis · RRMS · Relapsing Remitting MS

Abroad (travel likely)RecruitingPHASE2

San Francisco, United States